The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion.
Laszlo PeczelyTamas OllmannKristof LaszloLaszlo LenardAnthony A GracePublished in: The international journal of neuropsychopharmacology (2022)
In summary, quinpirole dose dependently regulates VTA DAergic activity as well as the motivation and motor behavior of the rats at the level of the VP.